Mice overexpressing wild-type human alpha-synuclein display alterations in colonic myenteric ganglia and defecation

Neurogastroenterology and Motility

Volumn 24, Issue 9, 2012, Pages

  Wang, L ^a   Magen, I ^b   Yuan, P Q ^a   Subramaniam, S R ^b   Richter, F ^b   Chesselet, M F ^b   Tache Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

synuclein; Colon; Defecation; Gastric emptying; Mice; Myenteric neurons; Peripheral choline acetyltransferase

Indexed keywords

ALPHA SYNUCLEIN; CHOLINE ACETYLTRANSFERASE; NEURONAL NITRIC OXIDE SYNTHASE; TYROSINE 3 MONOOXYGENASE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEFECATION; DESCENDING COLON; FOOD INTAKE; GANGLION; GASTROINTESTINAL MOTILITY DISORDER; GENOTYPE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MYENTERIC PLEXUS; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PARKINSON DISEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH EMPTYING; STRESS; WEIGHT REDUCTION;

ALPHA-SYNUCLEIN; ANIMALS; CHOLINE O-ACETYLTRANSFERASE; COLON; DEFECATION; GANGLIA, AUTONOMIC; GASTRIC EMPTYING; MALE; MICE; MICE, TRANSGENIC; MYENTERIC PLEXUS; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; PARKINSON DISEASE; TYROSINE 3-MONOOXYGENASE;

EID: 84865405580     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2012.01974.x     Document Type: Article

References (55)

1. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism Relat Disord 2011; 17: 10-5.
2. Savica R, Carlin JM, Grossardt BR et al. Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 2009; 73: 1752-8.
3. Abbott RD, Petrovitch H, White LR et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001; 57: 456-62.
4. Goetze O, Nikodem AB, Wiezcorek J et al. Predictors of gastric emptying in Parkinson's disease. Neurogastroenterol Motil 2006; 18: 369-75.
5. Tofaris GK, Spillantini MG. Physiological and pathological properties of alpha-synuclein. Cell Mol Life Sci 2007; 64: 2194-201.
6. Dickson DW, Braak H, Duda JE et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol 2009; 8: 1150-7.
7. Wakabayashi K, Takahashi H, Ohama E, Ikuta F. Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system. Acta Neuropathol (Berl) 1990; 79: 581-3.
8. Singaram C, Ashraf W, Gaumnitz EA et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995; 346: 861-4.
9. Braak H, de Vos RA, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006; 396: 67-72.
10. Kuo YM, Li Z, Jiao Y et al. Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 2010; 19: 1633-50.
11. Vance JM, Ali S, Bradley WG, Singer C, Di Monte DA. Gene-environment interactions in Parkinson's disease and other forms of parkinsonism. Neurotoxicology 2010; 31: 598-602.
12. Natale G, Kastsiushenka O, Fulceri F, Ruggieri S, Paparelli A, Fornai F. MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut. Brain Res 2010; 1355: 195-206.
13. Wang L, Fleming SM, Chesselet MF, Taché Y. Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. NeuroReport 2008; 19: 873-6.
14. Lam HA, Wu N, Cely I et al. Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human alpha-synuclein. J Neurosci Res 2011; 89: 1091-102.
15. Chesselet MF, Richter F. Modelling of Parkinson's disease in mice. Lancet Neurol 2011; 10: 1108-18.
16. Million M, Wang L, Stenzel-Poore MP et al. Enhanced pelvic responses to stressors in female CRF-overexpressing mice. Am J Physiol Regul Integr Comp Physiol 2007; 292: R1429-38.
17. Larauche M, Gourcerol G, Million M, Adelson DW, Taché Y. Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses. Stress 2010; 13: 343-54.
18. Gourcerol G, Wang L, Adelson DW, Larauche M, Taché Y, Million M. Cholinergic giant migrating contractions in conscious mouse colon assessed by using a novel noninvasive solid-state manometry method: modulation by stressors. Am J Physiol Gastrointest Liver Physiol 2009; 296: G992-1002.
19. Sang Q, Young HM. The identification and chemical coding of cholinergic neurons in the small and large intestine of the mouse. Anat Rec 1998; 251: 185-99.
20. Tooyama I, Kimura H. A protein encoded by an alternative splice variant of choline acetyltransferase mRNA is localized preferentially in peripheral nerve cells and fibers. J Chem Neuroanat 2000; 17: 217-26.
21. Wang L, Martinez V, Kimura H, Taché Y. 5-Hydroxytryptophan activates colonic myenteric neurons and propulsive motor function through 5-HT4 receptors in conscious mice. Am J Physiol Gastrointest Liver Physiol 2007; 292: G419-28.
22. Yuan PQ, Million M, Wu SV, Rivier J, Taché Y. Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats. Neurogastroenterol Motil 2007; 19: 923-36.
23. Rockenstein E, Mallory M, Hashimoto M et al. Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters. J Neurosci Res 2002; 68: 568-78.
24. Fleming SM, Salcedo J, Hutson CB et al. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype alpha-synuclein. Neuroscience 2006; 142: 1245-53.
25. Wang L, Stengel A, Goebel M et al. Peripheral activation of corticotropin-releasing factor receptor 2 inhibits food intake and alters meal structures in mice. Peptides 2011; 32: 51-9.
26. Hickey MA, Gallant K, Gross GG, Levine MS, Chesselet MF. Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing. Neurobiol Dis 2005; 20: 1-11.
27. Martinez V, Wang L, Rivier JE, Vale W, Taché Y. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: role of CRF receptor subtypes 1 and 2. J Pharmacol Exp Ther 2002; 301: 611-7.
28. Wang L, Martinez V, Rivier JE, Taché Y. Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am J Physiol Regul Integr Comp Physiol 2001; 281: R1401-10.
29. Milner LC, Crabbe JC. Three murine anxiety models: results from multiple inbred strain comparisons. Genes Brain Behav 2008; 7: 496-505.
30. Carai MA, Colombo G, Gessa GL, Yalamanchili R, Basavarajappa BS, Hungund BL. Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice. Br J Pharmacol 2006; 148: 1043-50.
31. Shannon KM, Keshavarzian A, Mutlu E et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 2012; 27: 709-715.
32. Lebouvier T, Neunlist M, Bruley d V et al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One 2010; 5: e12728.
33. Beach TG, Adler CH, Sue LI et al. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 2010; 119: 689-702.
34. Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H. Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 2010; 120: 1-12.
35. Braak E, Sandmann-Keil D, Rub U et al. Alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei. Acta Neuropathol 2001; 101: 195-201.
36. Bloch A, Probst A, Bissig H, Adams H, Tolnay M. Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 2006; 32: 284-95.
37. Monnikes H, Schmidt BG, Tebbe J, Bauer C, Taché Y. Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats. Brain Res 1994; 644: 101-8.
38. Bonaz B, Martin L, Beurriand E, Manier M, Hostein J, Feuerstein C. Locus ceruleus modulates migrating myoelectric complex in rats. Am J Physiol 1992; 262: G1121-6.
39. Million M, Wang L, Martinez V, Taché Y. Differential Fos expression in the paraventricular nucleus of the hypothalamus, sacral parasympathetic nucleus and colonic motor response to water avoidance stress in fischer and Lewis rats. Brain Res 2000; 877: 345-53.
40. Auluck PK, Caraveo G, Lindquist S. Alpha-synuclein: membrane interactions and toxicity in Parkinson's disease. Annu Rev Cell Dev Biol 2010; 26: 211-33.
41. Liu Z, Sakakibara R, Odaka T et al. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov Disord 2005; 20: 680-6.
42. Marrachelli VG, Miranda FJ, Alabadi JA et al. Perivascular nerve fiber alpha-synuclein regulates contractility of mouse aorta: a link to autonomic dysfunction in Parkinson's disease. Neurochem Int 2010; 56: 991-8.
43. Li ZS, Pham TD, Tamir H, Chen JJ, Gershon MD. Enteric dopaminergic neurons: definition, developmental lineage, and effects of extrinsic denervation. J Neurosci 2004; 24: 1330-9.
44. Qu ZD, Thacker M, Castelucci P, Bagyanszki M, Epstein ML, Furness JB. Immunohistochemical analysis of neuron types in the mouse small intestine. Cell Tissue Res 2008; 334: 147-61.
45. Anderson G, Noorian AR, Taylor G et al. Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease. Exp Neurol 2007; 207: 4-12.
46. Zheng LF, Wang ZY, Li XF et al. Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease. Brain Res 2011; 1420: 59-67.
47. Greene JG, Noorian AR, Srinivasan S. Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease. Exp Neurol 2009; 218: 154-61.
48. Hardoff R, Sula M, Tamir A et al. Gastric emptying time and gastric motility in patients with Parkinson's disease. Mov Disord 2001; 16: 1041-7.
49. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003; 2: 107-16.
50. Soykan I, Lin Z, Bennett JP, McCallum RW. Gastric myoelectrical activity in patients with Parkinson's disease: evidence of a primary gastric abnormality. Dig Dis Sci 1999; 44: 927-31.
51. Djaldetti R, Baron J, Ziv I, Melamed E. Gastric emptying in Parkinson's disease: patients with and without response fluctuations. Neurology 1996; 46: 1051-4.
52. Tanaka Y, Kato T, Nishida H et al. Is there a difference in gastric emptying between Parkinson's disease patients under long-term L-dopa therapy with and without motor fluctuations? An analysis using the (13)C-acetate breath test. J Neurol 2009; 256: 1972-6.
53. Robertson DR, Renwick AG, Macklin B et al. The influence of levodopa on gastric emptying in healthy elderly volunteers. Eur J Clin Pharmacol 1992; 42: 409-12.
54. Heetun ZS, Quigley EM. Gastroparesis and Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2012; 18: 433-44.
55. Korczyn AD, Gurevich T. Parkinson's disease: before the motor symptoms and beyond. J Neurol Sci 2010; 289: 2-6.